iifl-logo-icon 1

Shilpa Medicare Ltd Share Price

647
(0.47%)
Jul 23, 2024|10:19:59 AM

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Equities

Futures

Option

  • Open648
  • Day's High649.15
  • 52 Wk High685
  • Prev. Close644
  • Day's Low640.5
  • 52 Wk Low296.8
  • Turnover (lac)135.28
  • P/E183.4
  • Face Value1
  • Book Value270.43
  • EPS3.51
  • Mkt. Cap (Cr.)6,327.07
  • Div. Yield0
No Records Found

Shilpa Medicare Ltd KEY RATIOS

Sector

Pharmaceuticals

Open

648

Prev. Close

644

Turnover(Lac.)

135.28

Day's High

649.15

Day's Low

640.5

52 Week's High

685

52 Week's Low

296.8

Book Value

270.43

Face Value

1

Mkt Cap (₹ Cr.)

6,327.07

P/E

183.4

EPS

3.51

Divi. Yield

0

Shilpa Medicare Ltd Corporate Action

16 May 2024

12:00 AM

Board Meeting

Agenda : Audited Result

arrow

1 Sep 2023

12:00 AM

AGM

Announcement Date: 01 Sep, 2023

arrow

1 Sep 2023

12:00 AM

BookCloser

arrow

Shilpa Medicare Ltd NEWS AND UPDATE

No data found

Invest wise with Expert advice

By continuing, I accept the T&C and agree to receive communication on Whatsapp

Shilpa Medicare Ltd SHAREHOLDING SNAPSHOT

23 Jul, 2024|10:40 AM
  • Foreign Promoter
  • Indian Promoter
  • Institutions
  • Non Institutions
  • Custodies

Promoter- 44.39%

Foreign: 0.00%

Indian: 44.39%

Non-Promoter- 16.68%

Institutions: 16.68%

Non-Institutions: 38.92%

Custodian: 0.00%

Share Price

Shilpa Medicare Ltd FINANCIALS

Balance Sheet

Profit & Loss

Cash Flow

Ratios

Results

Loading...
Y/e 31 Mar( In .Cr)Mar-2023Mar-2022Mar-2021Mar-2020

Equity Capital

8.68

8.68

8.15

8.15

Preference Capital

0

0

0

0

Reserves

2,108.9

2,056.99

1,629.68

1,445.27

Net Worth

2,117.58

2,065.67

1,637.83

1,453.42

Minority Interest

View Balance Sheet
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Revenue

830.31

805.97

741.29

733.67

yoy growth (%)

3.02

8.72

1.03

8.56

Raw materials

-256.59

-265.56

-351.75

-368.79

As % of sales

30.9

32.95

47.45

50.26

Employee costs

-175.62

-149.27

-113.08

-91.52

View Profit & Loss
Loading...
Y/e 31 Mar( In .Cr)Mar-2021Mar-2020Mar-2018Mar-2017

Profit before tax

202.59

216.88

167.48

173.07

Depreciation

-40.84

-34.95

-32.77

-26.65

Tax paid

-71.14

-44.14

-34.24

-41.08

Working capital

-128.78

363.22

45.82

201.3

Other operating items

View Cash Flow
Loading...
Y/e 31 MarMar-2021Mar-2020Mar-2018Mar-2017

Growth matrix (%)

Revenue growth

3.02

8.72

1.03

8.56

Op profit growth

-7.3

36.76

-1.95

11.06

EBIT growth

-0.52

30.42

-3.56

13.91

Net profit growth

-4.81

45.39

4.54

12.92

View Ratios
Particulars (Rupees in Crores.)Mar-2024Mar-2023Mar-2022Mar-2021Mar-2020

Gross Sales

1,151.6

1,050.11

1,145.52

901.13

907.91

Excise Duty

0

0

0

0

0

Net Sales

1,151.6

1,050.11

1,145.52

901.13

907.91

Other Operating Income

0

0

0

0

0

Other Income

14.3

17.4

23.04

90.98

16.94

Shilpa Medicare Ltd Peer Comparison

Company Name
LTP
(₹)
P/E
(%)
Mkt.Cap
(₹Cr.)
NP Qtr
(₹Cr.)
Div.Yield
(%)
Sales Qtr
(₹.Cr)
Book Value
(₹)

Sun Pharmaceuticals Industries Ltd

SUNPHARMA

1,587.35

124.833,80,990.4867.60.855,536.9998.75

Divis Laboratories Ltd

DIVISLAB

4,534.8

76.421,20,383.365310.662,259507.93

Cipla Ltd

CIPLA

1,490

32.381,20,295.961,038.40.573,444.92346.41

Zydus Lifesciences Ltd

ZYDUSLIFE

1,154.55

33.791,16,159.651,405.20.263,172.6156.19

Dr Reddys Laboratories Ltd

DRREDDY

6,770.9

26.361,12,931.21,034.80.595,081.81,458.96

Figures of Market Capital(Mar Cap), Quarterly Net Profit(NP Qtr) and Quarterly Sales(Sales Qtr) are in ₹ Cr.

MORE ABOUT Shilpa Medicare Ltd

Management

Register Office

Registrar Office

Chairman (Non-Executive)

Omprakash Inani

Managing Director

Vishnukant Bhutada

Whole-time Director

Sharath Reddy Kalakota

Independent Director

Arvind Vasudeva

Independent Director

Hetal Gandhi

Company Sec. & Compli. Officer

Ritu Tiwary

Independent Director

Kamal K Sharma

Independent Director

Anita Bandyopadhyay

Registered Office


Tel: -

Website: -

Email: -

Registrar Office


Tel: -

Website: -

Email: -

Summary

Shilpa Medicare Limited (formerly known as Shilpa Antibiotics Limited) was incorporated as a Private Limited Company in November 20th, 1987 and has been promoted by Vishnukant C Bhutada and his associates. Shilpa Medicare Limited (SML) is engaged in manufacturing of Active Pharmaceutical Ingredients (API), Formulation and Development service. The Company started its operations as API manufacturer way back in 1987 at Raichur, Karnataka. The company started commercial production in November 1989. In November 1993, Shilpa Medicare Limited was converted into a Public Limited Company. The Company is one of the leading API and formulations manufacturers with strong capabilities in the therapeutic area of oncology. It supplies more than 30 oncology APIs including key products such as Capecitabine, Gemcitabine Hydrochloride, Axitinib, Erlotinib Hydrochloride and Irinotecan Hydrochloride for various regulated markets including USA, Europe, Japan, South Korea, Russia, Mexico, Brazil, and other emerging markets. While SMLs underlying expertise is in the field of oncology, it also derives revenue from sale of non-oncology APIs. With key products being Ambroxol (Mucolytic agent) in Europe and Tranexmic Acid and Ursodeoxycholic acid in India.SMLs product range includes over 44 oncology and non-oncology APIs. The Companys formulation product range consists of 16 injectable dosage forms, 19 oral solid dosage forms under SML and 13 formulations under SMLs wholly owned subsidiary Shilpa Therap
Read More

Company FAQs

What is the Shilpa Medicare Ltd share price today?

Down Arrow

The Shilpa Medicare Ltd shares price on N/A is Rs.₹646.65 today.

What is the Market Cap of Shilpa Medicare Ltd?

Down Arrow

Market capitalization, short for market cap, is the market value of a publicly traded company's outstanding shares. The market cap of Shilpa Medicare Ltd is ₹6323.65 Cr. as of 23 Jul ‘24

What is the PE and PB ratio of Shilpa Medicare Ltd?

Down Arrow

The PE and PB ratios of Shilpa Medicare Ltd is 183.4 and 2.38 as of 23 Jul ‘24

What is the 52 Week High and Low of Shilpa Medicare Ltd?

Down Arrow

The 52-week high/low is the highest and lowest price at which a Shilpa Medicare Ltd stock has traded during that given time period (similar to 1 year) and is considered as a technical indicator. The 52 week high and low of Shilpa Medicare Ltd is ₹296.45 and ₹685 as of 23 Jul ‘24

What is the CAGR of Shilpa Medicare Ltd?

Down Arrow

Shilpa Medicare Ltd's CAGR for 5 Years at 13.63%, 3 Years at 0.08%, 1 Year at 104.37%, 6 Month at 99.52%, 3 Month at 20.15% and 1 Month at 8.04%.

What is the shareholding pattern of Shilpa Medicare Ltd?

Down Arrow

The shareholding pattern of Shilpa Medicare Ltd is as follows:
Promoters - 44.39 %
Institutions - 16.69 %
Public - 38.92 %

Knowledge Centerplus
Logo

Logo IIFL Customer Care Number
(Gold/NCD/NBFC/Insurance/NPS)
1860-267-3000 / 7039-050-000

Logo IIFL Securities Support WhatsApp Number
+91 9892691696

Download The App Now

appapp
Knowledge Centerplus

Follow us on

facebooktwitterrssyoutubeinstagramlinkedin

2024, IIFL Securities Ltd. All Rights Reserved

ATTENTION INVESTORS
  • Prevent Unauthorized Transactions in your demat / trading account Update your Mobile Number/ email Id with your stock broker / Depository Participant. Receive information of your transactions directly from Exchanges on your mobile / email at the end of day and alerts on your registered mobile for all debits and other important transactions in your demat account directly from NSDL/ CDSL on the same day." - Issued in the interest of investors.
  • KYC is one time exercise while dealing in securities markets - once KYC is done through a SEBI registered intermediary (broker, DP, Mutual Fund etc.), you need not undergo the same process again when you approach another intermediary.
  • No need to issue cheques by investors while subscribing to IPO. Just write the bank account number and sign in the application form to authorise your bank to make payment in case of allotment. No worries for refund as the money remains in investor's account."

www.indiainfoline.com is part of the IIFL Group, a leading financial services player and a diversified NBFC. The site provides comprehensive and real time information on Indian corporates, sectors, financial markets and economy. On the site we feature industry and political leaders, entrepreneurs, and trend setters. The research, personal finance and market tutorial sections are widely followed by students, academia, corporates and investors among others.

RISK DISCLOSURE ON DERIVATIVES
  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to Rs. 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.
Copyright © IIFL Securities Ltd. All rights Reserved.

Stock Broker SEBI Regn. No: INZ000164132, PMS SEBI Regn. No: INP000002213,IA SEBI Regn. No: INA000000623, SEBI RA Regn. No: INH000000248

plus
We are ISO 27001:2013 Certified.

This Certificate Demonstrates That IIFL As An Organization Has Defined And Put In Place Best-Practice Information Security Processes.